Diet and Exercise Remains Key Says Slimming Coach as Weightloss Pill Hits the Market
Trial data show adults lost 14% to 17% of body weight after 64 weeks, and about one in three lost 20% or more.
4 Articles
4 Articles
The Wegovy weight-loss pill: what you need to know
The upcoming release of the UK’s first weight-loss pill, Wegovy, has been described as “game-changing” by a leading pharmacy provider. “We’ve already seen record demand ahead of the expected launch”, said James O’Loan, chief executive of Chemist4U. With the majority of people expressing interest in the new obesity treatment not being previous users of weight-loss injections, this indicated that the new pill “could widen access to millions of peo…
Novo Nordisk moves to launch Wegovy tablet in China
A race over obesity treatments is heating up in China, as global pharmaceutical giants compete to dominate the fast-growing market for weight-loss drugs. Danish pharmaceutical company Novo Nordisk says it … The post Novo Nordisk moves to launch Wegovy tablet in China appeared first on Scandasia.
UK waitlist for Novo's Wegovy pill triples in week after approval, major online pharmacy says
The waiting list at Chemist4U for Novo Nordisk’s Wegovy pill now stands at 30,000 people a week after approval, in a sign of dramatic demand for the weight loss drug among patients willing to pay out of pocket.
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
